During the past decade, Ospedale delle Croci - Ematologia conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale delle Croci - Ematologia" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 12 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 5 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "International Extranodal Lymphoma Study Group (IELSG)" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale delle Croci - Ematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale delle Croci - Ematologia" are "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Hodgkin Lymphoma" (2 trials), "Mantle Cell Lymphoma" (2 trials) and "Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "Ospedale delle Croci - Ematologia" in a lesser frequency.

Most popular intervention types in "Ospedale delle Croci - Ematologia" are "Drug" (28 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (6 trials), "Cyclophosphamide" (5 trials), "Venetoclax" (5 trials), "Bendamustine" (3 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale delle Croci - Ematologia" are 28 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale delle Croci - Ematologia". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ospedale delle Croci - Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale delle Croci - Ematologia, 5 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".